Laczym Chewable Tablet (Lactase)

Therapeutic Group : Enzyme

Presentation:

Laczym chewable tablet: Each chewable tablet contains Lactase USP 9000 IU.

Indications:

Laczym is indicated for preventing symptoms of lactose intolerance such as bloating, flatulence, diarrhea etc.

Dosage & Administration:

1 tablet with dairy food. If needed dose can be adjusted up to 2 tablets at a time.

Contrainidications:

This drug is contraindicated in patients with known hypersensitivity to lactase or any other components of the product.

Side effects:

There are no major side effects reported. The very few side effects may include rash, difficulty in breathing, tightness in chest etc.

Drug interaction:

No information for lactase interactions has been found yet.

Use in special groups:

Use in Pregnancy: It is unknown if lactase may cause harm to the fetus. Therefore, lactase should be given during pregnancy only when clearly needed.
Use in lactating mother: It is unknown if lactase is excreted in breast milk. Thus, lactase should be given during lactation only when clearly needed.
Use in children: Effective & safe in children above 4 years of age.

Packing:

Laczym chewable tablet: Each box contains 20 tablets in blister pack.